The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Timothy Norris Irish net worth and biography

Timothy Irish Biography and Net Worth

Director of iCAD

Timothy Norris Irish is a businessperson who has been at the head of 7 different companies. Presently, Mr. Irish occupies the position of Chairman-Supervisory Board of eZono AG and Chairman-Supervisory Board for QUIREM Medical BV. Mr. Irish is also on the board of 7 other companies.

He previously occupied the position of Chairman for Nexstim Oyj, Chairman at Bioxydyn Ltd., Senior Manager-Product at GlaxoSmithKline Plc, Chairman-Supervisory Board at BMEYE BV, Chairman for Version 1 Solutions Ltd., Vice President & General Manager at GE Healthcare Ltd. (United Kingdom), Senior VP, Chief Marketing & Strategy Officer at Philips Medical Systems, Senior VP, Chief Marketing & Strategy Officer at Philips Healthcare and Independent Non-Executive Director at National Institute for Health & Care Excellence.

He received a graduate degree from Imperial College London, a graduate degree from London School of Economics & Political Science, a graduate degree from University College London, an MBA from the University of Durham and an undergraduate degree from The University of Liverpool.

How do I contact Timothy Norris Irish?: The corporate mailing address for Mr. Irish and other iCAD executives is 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062. iCAD can also be reached via phone at (603) 882-5200 and via email at [email protected]. Learn More on Timothy Norris Irish's contact information.
Has Timothy Norris Irish been buying or selling shares of iCAD?: Timothy Norris Irish has not been actively trading shares of iCAD during the last ninety days. Most recently, on Thursday, March 3rd, Timothy Norris Irish bought 5,500 shares of iCAD stock. The stock was acquired at an average cost of $4.63 per share, with a total value of $25,465.00. Learn More on Timothy Norris Irish's trading history.
Who are iCAD's active insiders?: iCAD's insider roster includes Charles Carter (CFO), Jonathan Go (CTO), Timothy Irish (Director), Michael Klein (CEO), Andy Sassine (Director), Stacey Stevens (President), and Susan Wood (Director). Learn More on iCAD's active insiders.

Timothy Norris Irish Insider Trading History at iCAD

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/3/2022	Buy	5,500	$4.63	$25,465.00

Timothy Norris Irish Buying and Selling Activity at iCAD

iCAD Company Overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Today's Range

Now: $1.60

$1.49

$1.60

50 Day Range

MA: $1.72

$1.39

$2.40

2 Week Range

Now: $1.60

$1.18

$2.65

Volume

138,550 shs

Average Volume

174,536 shs

Market Capitalization

$42.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Top "Sleeping Giant" Crypto In The Market Now

From Crypto 101 Media | Ad

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late